Shanghai Pharmaceuticals Holding Co., Ltd Stock Other OTC
Stocks
SHPMY
US81943R1005
Pharmaceuticals
OTC Markets Traded| Market Cap | 56.5B 8.34B 7.29B 6.74B 6.23B 11.72B 801B 11.94B 80.37B 31.53B 392B 31.33B 30.64B 1,351B | P/E 2026 * |
11.5x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 61.17B 9.03B 7.89B 7.3B 6.74B 12.69B 867B 12.92B 87.01B 34.14B 425B 33.92B 33.17B 1,463B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.22x |
| Free-Float |
41.21% | Yield 2026 * |
2.61% | Yield 2027 * | 2.87% |
| 1 day | -3.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Zhong Li
PSD | President | 56 | 29/06/2023 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 05/06/2013 |
Xue Jun Cai
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 28/06/2016 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 27/06/2019 |
You Li Xu
CHM | Chairman | 51 | 29/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.18% | +4.04% | - | - | 8.23B | |
| +0.22% | -1.89% | +12.99% | +95.10% | 94.06B | |
| -0.52% | -3.59% | +42.00% | +144.62% | 53.89B | |
| +0.34% | +4.64% | +6.93% | +283.01% | 23.47B | |
| +2.67% | +2.43% | -25.91% | -33.27% | 7.75B | |
| +2.59% | +1.57% | -6.78% | -27.59% | 6.77B | |
| +0.19% | -4.82% | +20.96% | +30.31% | 6.11B | |
| -0.17% | +0.58% | -1.64% | +22.36% | 5.37B | |
| +2.96% | +5.25% | -5.27% | -3.99% | 3.84B | |
| +3.91% | +0.98% | +15.72% | +18.51% | 3.38B | |
| Average | +0.90% | -0.02% | +6.55% | +58.78% | 22.74B | |
| Weighted average by Cap. | +0.16% | -0.84% | +17.36% | +113.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 297B 43.89B 38.36B 35.46B 32.76B 61.69B 4,216B 62.81B 423B 166B 2,064B 165B 161B 7,108B | 315B 46.54B 40.67B 37.6B 34.74B 65.42B 4,471B 66.6B 448B 176B 2,189B 175B 171B 7,538B |
| Net income | 5.35B 789M 690M 638M 589M 1.11B 75.81B 1.13B 7.6B 2.98B 37.12B 2.96B 2.9B 128B | 5.6B 827M 723M 668M 617M 1.16B 79.45B 1.18B 7.97B 3.13B 38.91B 3.11B 3.04B 134B |
| Net Debt | 4.67B 690M 603M 557M 515M 969M 66.24B 987M 6.64B 2.61B 32.43B 2.59B 2.53B 112B | 12.67B 1.87B 1.63B 1.51B 1.4B 2.63B 180B 2.68B 18.02B 7.07B 87.96B 7.02B 6.87B 303B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
